Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Autoimmunity|April 15, 2010
Development of small-molecule therapies for autoimmune diseasesRoland W Bürli, Alan F Haughan, Alastair J Hodges
Nature Chemical Biology|January 29, 2021
VCP/p97 regulates Beclin-1-dependent autophagy initiationSandra M Hill, Lidia Wrobel, Avraham Ashkenazi, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 2: C-terminal benzimidazoles and derivativesRoland W Bürli, Peter Jones, Dustin McMinn, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
DNA binding ligands with excellent antibiotic potency against drug-resistant gram-positive bacteriaRoland W Bürli, Yigong Ge, Sarah White, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzymeGonzalo S Tejeda, Ellanor L Whiteley, Tarek Z Deeb, et al.
Bioorganic & Medicinal Chemistry Letters|October 9, 2007
New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammationMike Frohn, Han Xu, Xiaoming Zou, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivativesRoland W Bürli, Dustin McMinn, Jacob A Kaizerman, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitorsMike Frohn, Vellarkad Viswanadhan, Alexander J Pickrell, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agentsRoland W Bürli, Han Xu, Xiaoming Zou, et al.
Pageof 4